Jonathan Emord, “The FDA’s bow to barbarism” (Washington Times, Oct. 12, 2016)
Read Jonathan Emord’s October 12, 2016 article in the Washington Times concerning the FDA’s untenable decision to downgrade Electroconvulsive Therapy (ECT) medical devices from Class III to Class II: The FDA’s bow to barbarism: Downgrading the brain injury risks from shock therapy is unjustified (Oct. 12, 2016) (opens in new window)
